Cargando…

Association of collagen deep learning classifier with prognosis and chemotherapy benefits in stage II‐III colon cancer

The current tumor‐node‐metastasis staging system does not provide sufficient prognostic prediction or adjuvant chemotherapy benefit information for stage II‐III colon cancer (CC) patients. Collagen in the tumor microenvironment affects the biological behaviors and chemotherapy response of cancer cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Wei, Wang, Huaiming, Chen, Weisheng, Zhao, Yandong, Yan, Botao, Chen, Dexin, Dong, Xiaoyu, Cheng, Jiaxin, Lin, Zexi, Zhuo, Shuangmu, Wang, Hui, Yan, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189440/ https://www.ncbi.nlm.nih.gov/pubmed/37206212 http://dx.doi.org/10.1002/btm2.10526

Ejemplares similares

A nomogram based on collagen signature for predicting the immunoscore in colorectal cancer
por: Jiang, Wei, et al.
Publicado: (2023)

Development and validation of a collagen signature to predict the prognosis of patients with stage II/III colorectal cancer
por: Dong, Shumin, et al.
Publicado: (2023)

Post-operative anastomotic leakage and collagen changes in patients with rectal cancer undergoing neoadjuvant chemotherapy vs chemoradiotherapy
por: Jiang, Wei, et al.
Publicado: (2022)

Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer
por: Chen, Dexin, et al.
Publicado: (2021)

Predicting postoperative peritoneal metastasis in gastric cancer with serosal invasion using a collagen nomogram
por: Chen, Dexin, et al.
Publicado: (2021)

Use of patient‐derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Xue, Weisong, et al.
Publicado: (2023)

Development and validation of a collagen signature-based nomogram for preoperatively predicting lymph node metastasis and prognosis in colorectal cancer
por: Fu, Meiting, et al.
Publicado: (2021)

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
por: Chen, Xin, et al.
Publicado: (2022)

Association of the collagen signature with pathological complete response in rectal cancer patients
por: Jiang, Wei, et al.
Publicado: (2022)

Label-free monitoring of colonic cancer progression using multiphoton microscopy
por: Zhuo, Shuangmu, et al.
Publicado: (2011)

Evaluation of a 55-gene classifier as a prognostic biomarker for adjuvant chemotherapy in stage III colon cancer patients
por: Oki, Eiji, et al.
Publicado: (2021)

Label-Free Imaging of Basement Membranes Differentiates Normal, Precancerous, and Cancerous Colonic Tissues by Second-Harmonic Generation Microscopy
por: Zhuo, Shuangmu, et al.
Publicado: (2012)

Prognostic and predictive value of a pathomics signature in gastric cancer
por: Chen, Dexin, et al.
Publicado: (2022)

Stage III deficient mismatch repair colon patients get greater benefit from earlier starting oxaliplatin-based chemotherapy regimen
por: Zhan, Yixiang, et al.
Publicado: (2023)

Real-time optical diagnosis of gastric cancer with serosal invasion using multiphoton imaging
por: Yan, Jun, et al.
Publicado: (2016)

Adjuvant Chemotherapy for Stage III Colon Cancer
por: Taieb, Julien, et al.
Publicado: (2020)

Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair
por: Hu, Huabin, et al.
Publicado: (2020)

Development and validation of a robust necroptosis related classifier for colon adenocarcinoma
por: Yang, Jie, et al.
Publicado: (2022)

Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2019)

Label-free and real-time imaging of dehydration-induced DNA conformational changes in cellular nucleus using second harmonic microscopy
por: Zhuo, Shuangmu, et al.
Publicado: (2014)

Applications of self-assembling ultrashort peptides in bionanotechnology
por: Ni, Ming, et al.
Publicado: (2019)

Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer
por: Teufel, Andreas, et al.
Publicado: (2015)

KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer
por: Uil, Sjoerd H., et al.
Publicado: (2022)

Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study
por: Kawamura, Hidetaka, et al.
Publicado: (2020)

Survival benefit with adjuvant chemotherapy in stage III microsatellite-high/deficient mismatch repair colon cancer: a systematic review and meta-analysis
por: Tomasello, Gianluca, et al.
Publicado: (2022)

Benefit of Uracil–Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer
por: Chen, Po-Huang, et al.
Publicado: (2022)

Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70
por: Lu, Chieh-Sheng, et al.
Publicado: (2015)

Impact of HER2 on prognosis and benefit from adjuvant chemotherapy in stage II/III gastric cancer patients: a multicenter observational study
por: Gao, Xianchun, et al.
Publicado: (2023)

Predictors of Malignancy in Thyroid Nodules Classified as Bethesda Category III
por: Liu, Xiaoli, et al.
Publicado: (2022)

Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study
por: Gao, Peng, et al.
Publicado: (2018)

Collagen Type III Glomerulopathy
por: Wilson, AnnaLisa V., et al.
Publicado: (2021)

Large-scale tumor-associated collagen signatures identify high-risk breast cancer patients
por: Xi, Gangqin, et al.
Publicado: (2021)

Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer
por: Lee, Mok-Won, et al.
Publicado: (2021)

Regulation of Collagen I and Collagen III in Tissue Injury and Regeneration
por: Singh, Drishtant, et al.
Publicado: (2023)

PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy
por: Chen, Jian, et al.
Publicado: (2014)

The Role of Tumor Deposits in Predicting the Efficacy of Chemotherapy in Stage III Colon Cancer
por: Shi, Mingyu, et al.
Publicado: (2020)

Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer
por: Karim, Safiya, et al.
Publicado: (2019)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

Garment Design Models Combining Bayesian Classifier and Decision Tree Algorithm
por: Yan, Xiaoyu, et al.
Publicado: (2022)

Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer
por: Liu, Qi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u80p405k2jqea5fnct21fmdf9e